| Dr Ravin Jain Garg, MD | |
|
2003 Medical Parkway, Suite 210, Annapolis, MD 21401-3093 | |
| (410) 571-5300 | |
| (410) 571-5305 |
| Full Name | Dr Ravin Jain Garg |
|---|---|
| Gender | Male |
| Speciality | Medical Oncology |
| Experience | 21 Years |
| Location | 2003 Medical Parkway, Annapolis, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043385180 | NPI | - | NPPES |
| 011815000 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | D64852 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hospice Of The Chesapeake | Pasadena, MD | Hospice |
| Anne Arundel Medical Center | Annapolis, MD | Hospital |
| University Of Md Baltimore Washington Medical Center | Glen burnie, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Maryland Oncology Hematology Pa | 2062302102 | 80 |
News Archive
A Canadian research team reports a substantial increase in the use of preoperative magnetic resonance imaging over a 10-year period in women with newly diagnosed breast cancer.
Mutual-help groups for addiction have proliferated, diversified, and adapted to emerging substance-related trends over the past 75 years. A new special, triple issue of the Journal of Groups in Addiction & Recovery - Broadening the Base of Addiction Mutual Support: Bringing Theory and Science to Contemporary Trends - reviews the history of mutual-support groups for addiction that have arisen as adjuncts or alternatives to Twelve Step Programs.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Extended-release (ER) Tablets, 500 mg and 750 mg.
Autism Speaks, the world's largest autism science and advocacy organization, together with First Signs, a leader in educating parents and professionals about the early signs of autism and related disorders, and Florida State University's Autism Institute today announced the launch of a new treatment section of its acclaimed online Autism Video Glossary, giving parents an important new tool as they work to determine the best treatment options for their child.
Empagliflozin (trade name Jardiance) has been approved since May 2014 for adults with type 2 diabetes mellitus in whom diet and exercise alone do not provide adequate glycaemic control.
› Verified 1 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719 |
News Archive
A Canadian research team reports a substantial increase in the use of preoperative magnetic resonance imaging over a 10-year period in women with newly diagnosed breast cancer.
Mutual-help groups for addiction have proliferated, diversified, and adapted to emerging substance-related trends over the past 75 years. A new special, triple issue of the Journal of Groups in Addiction & Recovery - Broadening the Base of Addiction Mutual Support: Bringing Theory and Science to Contemporary Trends - reviews the history of mutual-support groups for addiction that have arisen as adjuncts or alternatives to Twelve Step Programs.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Extended-release (ER) Tablets, 500 mg and 750 mg.
Autism Speaks, the world's largest autism science and advocacy organization, together with First Signs, a leader in educating parents and professionals about the early signs of autism and related disorders, and Florida State University's Autism Institute today announced the launch of a new treatment section of its acclaimed online Autism Video Glossary, giving parents an important new tool as they work to determine the best treatment options for their child.
Empagliflozin (trade name Jardiance) has been approved since May 2014 for adults with type 2 diabetes mellitus in whom diet and exercise alone do not provide adequate glycaemic control.
› Verified 1 days ago
| Entity Name | University Of Maryland Community Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477530624 PECOS PAC ID: 3678472214 Enrollment ID: O20040102000687 |
News Archive
A Canadian research team reports a substantial increase in the use of preoperative magnetic resonance imaging over a 10-year period in women with newly diagnosed breast cancer.
Mutual-help groups for addiction have proliferated, diversified, and adapted to emerging substance-related trends over the past 75 years. A new special, triple issue of the Journal of Groups in Addiction & Recovery - Broadening the Base of Addiction Mutual Support: Bringing Theory and Science to Contemporary Trends - reviews the history of mutual-support groups for addiction that have arisen as adjuncts or alternatives to Twelve Step Programs.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Extended-release (ER) Tablets, 500 mg and 750 mg.
Autism Speaks, the world's largest autism science and advocacy organization, together with First Signs, a leader in educating parents and professionals about the early signs of autism and related disorders, and Florida State University's Autism Institute today announced the launch of a new treatment section of its acclaimed online Autism Video Glossary, giving parents an important new tool as they work to determine the best treatment options for their child.
Empagliflozin (trade name Jardiance) has been approved since May 2014 for adults with type 2 diabetes mellitus in whom diet and exercise alone do not provide adequate glycaemic control.
› Verified 1 days ago
| Entity Name | Maryland Oncology Hematology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396710703 PECOS PAC ID: 2062302102 Enrollment ID: O20040319001169 |
News Archive
A Canadian research team reports a substantial increase in the use of preoperative magnetic resonance imaging over a 10-year period in women with newly diagnosed breast cancer.
Mutual-help groups for addiction have proliferated, diversified, and adapted to emerging substance-related trends over the past 75 years. A new special, triple issue of the Journal of Groups in Addiction & Recovery - Broadening the Base of Addiction Mutual Support: Bringing Theory and Science to Contemporary Trends - reviews the history of mutual-support groups for addiction that have arisen as adjuncts or alternatives to Twelve Step Programs.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Extended-release (ER) Tablets, 500 mg and 750 mg.
Autism Speaks, the world's largest autism science and advocacy organization, together with First Signs, a leader in educating parents and professionals about the early signs of autism and related disorders, and Florida State University's Autism Institute today announced the launch of a new treatment section of its acclaimed online Autism Video Glossary, giving parents an important new tool as they work to determine the best treatment options for their child.
Empagliflozin (trade name Jardiance) has been approved since May 2014 for adults with type 2 diabetes mellitus in whom diet and exercise alone do not provide adequate glycaemic control.
› Verified 1 days ago
| Entity Name | Luminis Health Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073580205 PECOS PAC ID: 2860447315 Enrollment ID: O20050317000146 |
News Archive
A Canadian research team reports a substantial increase in the use of preoperative magnetic resonance imaging over a 10-year period in women with newly diagnosed breast cancer.
Mutual-help groups for addiction have proliferated, diversified, and adapted to emerging substance-related trends over the past 75 years. A new special, triple issue of the Journal of Groups in Addiction & Recovery - Broadening the Base of Addiction Mutual Support: Bringing Theory and Science to Contemporary Trends - reviews the history of mutual-support groups for addiction that have arisen as adjuncts or alternatives to Twelve Step Programs.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Extended-release (ER) Tablets, 500 mg and 750 mg.
Autism Speaks, the world's largest autism science and advocacy organization, together with First Signs, a leader in educating parents and professionals about the early signs of autism and related disorders, and Florida State University's Autism Institute today announced the launch of a new treatment section of its acclaimed online Autism Video Glossary, giving parents an important new tool as they work to determine the best treatment options for their child.
Empagliflozin (trade name Jardiance) has been approved since May 2014 for adults with type 2 diabetes mellitus in whom diet and exercise alone do not provide adequate glycaemic control.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ravin Jain Garg, MD Po Box 12622, Belfast, ME 04915-4017 Ph: (443) 481-6571 | Dr Ravin Jain Garg, MD 2003 Medical Parkway, Suite 210, Annapolis, MD 21401-3093 Ph: (410) 571-5300 |
News Archive
A Canadian research team reports a substantial increase in the use of preoperative magnetic resonance imaging over a 10-year period in women with newly diagnosed breast cancer.
Mutual-help groups for addiction have proliferated, diversified, and adapted to emerging substance-related trends over the past 75 years. A new special, triple issue of the Journal of Groups in Addiction & Recovery - Broadening the Base of Addiction Mutual Support: Bringing Theory and Science to Contemporary Trends - reviews the history of mutual-support groups for addiction that have arisen as adjuncts or alternatives to Twelve Step Programs.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Extended-release (ER) Tablets, 500 mg and 750 mg.
Autism Speaks, the world's largest autism science and advocacy organization, together with First Signs, a leader in educating parents and professionals about the early signs of autism and related disorders, and Florida State University's Autism Institute today announced the launch of a new treatment section of its acclaimed online Autism Video Glossary, giving parents an important new tool as they work to determine the best treatment options for their child.
Empagliflozin (trade name Jardiance) has been approved since May 2014 for adults with type 2 diabetes mellitus in whom diet and exercise alone do not provide adequate glycaemic control.
› Verified 1 days ago
Gashaw Adugna Dadi, M.D Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 240-495-4189 | |
Dr. Eugene Thomas Manion, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 900 Bestgate Road, Suite 303, Annapolis, MD 21401 Phone: 410-224-8220 Fax: 410-841-2482 | |
Dr. Lisa A Dimarzio, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2003 Medical Parkway, Suite 100, Annapolis, MD 21401 Phone: 410-573-1110 Fax: 410-266-0714 | |
Dr. Richard A Bernstein, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 133 Defense Hwy, Suite 109, Annapolis, MD 21401 Phone: 401-224-5558 Fax: 410-224-7321 | |
Dr. Jonathan A Altschuler, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2002 Medical Pkwy, Ste 500, Annapolis, MD 21401 Phone: 410-573-6480 Fax: 410-573-9413 | |
Dr. Ira M Weinstein, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2000 Medical Pkwy, Suite 607, Annapolis, MD 21401 Phone: 410-266-1644 Fax: 410-266-1642 | |
Dr. James M Blake, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 820 Bestgate Road, Suite 2a, Annapolis, MD 21401 Phone: 410-224-2116 Fax: 410-224-2118 |